Bio Protocol vs StakeStone — how do they compare? Bio Protocol trades at Rp514.7 (market cap Rp1,15T, Rp256,3M 24h volume), while StakeStone trades at Rp776 (market cap Rp174,93M, Rp80,76M 24h volume). The key difference: Bio Protocol is far larger — about 6574.1× StakeStone's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 225,3M / 1B STO (23%) for StakeStone. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and StakeStone for 10 Days on average.
| BIO | STO | |
|---|---|---|
Market Cap | Rp1,15T | Rp174,93M |
Volume (24h) | Rp256,3M | Rp80,76M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 225,3M / 1B STO (23%) |
Typical Hold Time | 16 Days | 10 Days |
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →StakeStone is a decentralized liquidity infrastructure protocol aimed at optimizing yield generation and liquidity distribution across blockchain networks. Its solutions—such as LiquidityPad and yield-bearing ETH/BTC assets—provide liquidity providers with efficient earning opportunities while addressing the unique liquidity needs of various ecosystems and protocols.
Read more on STO →